CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

Drug development collaboration with Orphazyme

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials

Read more

Bio€quity Europe 2018 Conference

CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients,…

Read more

CENTOGENE announces the appointment of a new Supervisory Board Member

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

Read more

Solutions for early diagnosis at the 2nd Rare Disease Conference

CENTOGENE highlights solutions for early diagnosis of rare hereditary disorders at the 2nd Annual Recent Advances in Rare Disease Conference.

CENTOGE…

Read more

Lyso-Gb1 for monitoring response to therapy for patients with Gaucher disease

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, announced the publication…

Read more

CENTOGENE expands Executive Team, appoints Dr. Dirk Ehlers Chief Operating Officer

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

Read more

CENTOGENE to present at the Cowen and Company 38th Annual Health Care Conference

CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference…

Read more

"50+new genes" initiative - "Un-Rare" rare diseases

There are more than 7,000 identified rare diseases where about 80% are hereditary. About 30 million Americans are living with a rare disease today;…

Read more

New findings in hypomyelinating leukodystrophy

We mark Rare Disease Day 2018 with continued commitment to reduce time to diagnosis of rare diseases.

Read more

Prof. Arndt Rolfs joins newly formed “Global Commission to End the Diagnostic Odyssey”

Prof. Arndt Rolfs has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a dedicated group of technology…

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads